EODData

FRA, 1OT: Ovid Therapeutics Inc

08 Apr 2026
LAST:

2.200

CHANGE:
 0.25
OPEN:
2.200
HIGH:
2.200
ASK:
0.000
VOLUME:
0
CHG(%):
12.82
PREV:
1.950
LOW:
2.200
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
08 Apr 262.2002.2002.2002.2000
07 Apr 261.9501.9501.9501.9508.9K
02 Apr 261.8101.8101.8101.8100
01 Apr 261.8801.8801.8801.8800
31 Mar 261.8001.8001.8001.8000
30 Mar 261.9601.9601.9201.9200
27 Mar 262.0802.0802.0802.0800
26 Mar 262.0402.0402.0402.0408.9K
25 Mar 262.0602.0602.0602.0608.9K
24 Mar 262.1602.2002.1602.2008.9K

PROFILE

Name:Ovid Therapeutics Inc
About:Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:441 Ninth Avenue, New York, NY, United States, 10001
Website:https://www.ovidrx.com
ISIN:US6904691010
LEI:549300H36NUI4L6U8F17

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-3.86 
Forward P/E:-1.72 
PEG Ratio:0.26 
Price to Sales:15.86 
Price to Book:2.68 
Operating Margin:-94.87 
Return on Assets:-0.29 
Return on Equity:-0.60 
Revenue:5.62M 
Shares:71.11M 
Market Cap:156.44M 

TECHNICAL INDICATORS

MA5:1.9314.1%
MA10:1.9910.3%
MA20:1.9115.2%
MA50:1.5442.6%
MA100:1.4155.6%
MA200:1.1099.2%
STO9:100.00 
STO14:100.00 
RSI14:67.72 
MTM14:0.49
ROC14:0.29 
ATR:0.12 
Week High:2.200.0%
Week Low:1.8121.5%
Month High:2.200.0%
Month Low:1.5899.2%
Year High:2.200.0%
Year Low:0.181,157.1%